Literature DB >> 22671578

Effect of captopril on infantile haemangiomas: a retrospective case series.

Elizabeth M Christou1, Orli Wargon.   

Abstract

The mechanism of action of beta adrenergic blockers in the involution of infantile haemangioma (IH) remains unclear. It has been proposed that the renin-angiotensin pathway may play a role. We present a retrospective case series of 17 patients with IH who were treated with oral corticosteroid therapy and developed hypertension requiring treatment with the angiotensin converting enzyme inhibitor, captopril. All patients, with written documentation, demonstrated an improvement in their lesion at the start of oral corticosteroid therapy (n = 14). Captopril alone did not sustain the corticosteroid-induced involution with a documented worsening of infantile haemangioma in seven out of 12 patients (58%).
© 2012 The Authors. Australasian Journal of Dermatology © 2012 The Australasian College of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22671578     DOI: 10.1111/j.1440-0960.2012.00901.x

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN: 0004-8380            Impact factor:   2.875


  5 in total

Review 1.  Pathogenesis of infantile haemangioma.

Authors:  S Greenberger; J Bischoff
Journal:  Br J Dermatol       Date:  2013-07       Impact factor: 9.302

Review 2.  Cardiovascular drugs in the treatment of infantile hemangioma.

Authors:  Israel Fernandez-Pineda; Regan Williams; Lucia Ortega-Laureano; Ryan Jones
Journal:  World J Cardiol       Date:  2016-01-26

Review 3.  Interventions for infantile haemangiomas of the skin.

Authors:  Monica Novoa; Eulalia Baselga; Sandra Beltran; Lucia Giraldo; Ali Shahbaz; Hector Pardo-Hernandez; Ingrid Arevalo-Rodriguez
Journal:  Cochrane Database Syst Rev       Date:  2018-04-18

Review 4.  Biology of infantile hemangioma.

Authors:  Tinte Itinteang; Aaron H J Withers; Paul F Davis; Swee T Tan
Journal:  Front Surg       Date:  2014-09-25

5.  Angiotensin-converting Enzyme Inhibitors: Can it be a Potential Treatment of Infantile Hemangioma.

Authors:  Archika Gupta; Shiv Narain Kureel; Anand Pandey; Gurmeet Singh; Akhilesh Kumar; Gaurav Shandilya; Rahul Kumar Rai; Survesh Kumar Gupta
Journal:  J Indian Assoc Pediatr Surg       Date:  2021-07-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.